Table 1 Concentrations of SCFAs in in-vitro incubation solutions at different time points.

From: Association of human gut microbiota composition and metabolic functions with Ficus hirta Vahl dietary supplementation

SCFAs

Samples

Anaerobic incubation time (h)

(mM)

0

3

6

12

24

Acetate

Control

FHVD

0.31 ± 0.02

0.34 ± 0.10 a

2.35 ± 0.25 b

1.99 ± 0.40 a

2.69 ± 0.41 b

2.07 ± 0.28 a

9.13 ± 0.70 b

5.79 ± 0.11 a

6.40 ± 0.80 b

Propionate

Control

FHVD

0.29 ± 0.02

0.51 ± 0.02 a

1.67 ± 0.15 b

1.36 ± 0.19 a

2.67 ± 0.27 b

1.26 ± 0.10 a

7.38 ± 0.46 b

3.40 ± 0.07 a

6.04 ± 0.57 b

Butyrate

Control

FHVD

0.33 ± 0.01

0.42 ± 0.02 a

0.88 ± 0.01 b

0.92 ± 0.06 a

1.59 ± 0.08 b

1.25 ± 0.10 a

5.54 ± 0.25 b

2.41 ± 0.02 a

5.46 ± 0.45 b

  1. Each data was conducted in triplicates, and the value was presented as Mean ± SD. Different lowercase letters indicate significant differences (P < 0.05) among different groups.
Back to article page